‌

US Patent 6887471 Method to inhibit T cell interactions with soluble B7

Patent 6887471 was granted and assigned to Bristol-Myers Squibb on May, 2005 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Something went wrong.

Try refreshing the page.

Find more entities like US Patent 6887471 Method to inhibit T cell interactions with soluble B7

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.